| Item Type | Name |
|
Concept
|
Narcotics
|
|
Concept
|
Narcotic Antagonists
|
|
Concept
|
Analgesics, Non-Narcotic
|
|
Academic Article
|
Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
|
|
Academic Article
|
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
|
|
Academic Article
|
Dose-related effects of oral acetaminophen on cold-induced pain: a double-blind, randomized, placebo-controlled trial.
|
|
Academic Article
|
Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study.
|
|
Academic Article
|
Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
|
|
Academic Article
|
Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
|
|
Academic Article
|
Antagonism of gastrointestinal opioid effects.
|
|
Academic Article
|
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
|
|
Academic Article
|
Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.
|
|
Academic Article
|
Effects of low-dose morphine on gastric emptying in healthy volunteers.
|
|
Academic Article
|
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
|
|
Academic Article
|
Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
|
|
Academic Article
|
Determination of methylnaltrexone in clinical samples by solid-phase extraction and high-performance liquid chromatography for a pharmacokinetics study.
|
|
Academic Article
|
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
|
|
Academic Article
|
Methylnaltrexone prevents morphine-induced kaolin intake in the rat.
|
|
Academic Article
|
Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
|
|
Academic Article
|
Kavalactones and dihydrokavain modulate GABAergic activity in a rat gastric-brainstem preparation.
|
|
Academic Article
|
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
|
|
Academic Article
|
Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
|
|
Academic Article
|
Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
|
|
Academic Article
|
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone.
|
|
Academic Article
|
Opioid-induced gastrointestinal dysfunction.
|
|
Academic Article
|
Methylnaltrexone potentiates body weight and fat reduction with leptin.
|
|
Academic Article
|
Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
|
|
Academic Article
|
Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine.
|
|
Academic Article
|
The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
|
|
Academic Article
|
Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
|
|
Academic Article
|
Methylnaltrexone reduced body weight gain in ob/ob mice.
|
|
Academic Article
|
Pharmacologic treatment of opioid-induced constipation.
|